{
    "clinical_study": {
        "@rank": "164758", 
        "brief_summary": {
            "textblock": "The study is designed to confirm safety and efficacy of the SD01 ICD (implantable\n      cardioverter-defibrillator) lead."
        }, 
        "brief_title": "SD01 Master Study (Safety and Efficacy Study)", 
        "completion_date": {
            "#text": "December 2019", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Ventricular Tachycardia", 
            "Ventricular Fibrillation", 
            "Heart Failure"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heart Failure", 
                "Tachycardia", 
                "Ventricular Fibrillation", 
                "Tachycardia, Ventricular"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Standard indication for an ICD/CRT-D therapy\n\n          -  Signed informed consent form\n\n          -  Patient is willing and able to participate for the whole study duration\n\n          -  Patient is willing and able to activate and use the CardioMessenger\n\n          -  Legal capacity and ability to consent.\n\n        Exclusion Criteria:\n\n          -  Standard contraindication for an ICD/CRT-D therapy\n\n          -  Age <18 years.\n\n          -  Pregnant or breastfeeding\n\n          -  Cardiac surgery is planned within the next six months\n\n          -  Any condition that in the opinion of the investigator would preclude compliance with\n             the study protocol during the whole follow-up period\n\n          -  Enrollment in another cardiac clinical investigation with active treatment arm\n\n          -  Mechanical tricuspid valve prosthesis or severe tricuspid valve disease\n\n          -  Dexamethasone acetate intolerance"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with standard ICD/CRT-D (cardiac resynchronization therapy plus defibrillator)\n        indication"
            }
        }, 
        "enrollment": {
            "#text": "160", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01836497", 
            "org_study_id": "62"
        }, 
        "intervention": {
            "intervention_name": "SD01 ICD lead", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 19, 2013", 
        "location": {
            "contact": {
                "email": "frank.bode@uk-sh.de", 
                "last_name": "Frank Bode, PD Dr. med."
            }, 
            "facility": {
                "address": {
                    "city": "L\u00fcbeck", 
                    "country": "Germany"
                }, 
                "name": "University Clinic of Schleswig-Holstein"
            }, 
            "investigator": {
                "last_name": "Frank Bode, PD Dr. med.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "SD01 Master Study (Safety and Efficacy Study)", 
        "overall_contact": {
            "email": "jens.buttgereit@biotronik.com", 
            "last_name": "Jens Buttgereit, Dr.", 
            "phone": "+49 30 68905", 
            "phone_ext": "1267"
        }, 
        "overall_official": {
            "affiliation": "University Clinic of Schleswig-Holstein, L\u00fcbeck, Germany", 
            "last_name": "Frank Bode, PD Dr. med.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Germany: Ethics Commission", 
                "Hungary: Office of Health Authorisation and Administrative Procedures", 
                "Czech Republic: Ethics Committee", 
                "Latvia: Ethics Committee", 
                "France: French medicines and healthcare products safety agency"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "The evaluation of right ventricular sensing performance is based on the assessment of consecutive intrinsic beats documented with markers on an IEGM (intra-cardiac electrogram). The evaluation of ventricular sensing performance is based on the data to be collected during the 3-month follow-up. The appropriate pacing performance in the right ventricle results from the evaluation of \"capture\" at the end of the 3-month follow-up.", 
                "measure": "Rate of appropriate sensing and pacing", 
                "safety_issue": "No", 
                "time_frame": "at the 3-month follow-up"
            }, 
            {
                "measure": "Serious adverse device effects (SADEs) related to the SD01 lead", 
                "safety_issue": "Yes", 
                "time_frame": "until the 3-month follow-up"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01836497"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Comparison of the manually measured pacing threshold of the SD01 lead system to the Linox SD lead at 3-month follow-up. The idea is that the pacing threshold will be similar within a suitable range.", 
                "measure": "Comparison of pacing threshold between Linoxsmart and SD01", 
                "safety_issue": "No", 
                "time_frame": "at the 3-month follow-up"
            }, 
            {
                "measure": "Shift rate of the painless shock impedance measurement", 
                "safety_issue": "Yes", 
                "time_frame": "between 3- and 6-month follow-up"
            }
        ], 
        "source": "Biotronik SE & Co. KG", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Biotronik SE & Co. KG", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2013"
    }
}